MU Micron Technology | $1,133.99
| 6/18/2026 | | Boost Price Target | $500.00 ➝ $1,300.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/18/2026 |
PLTR Palantir Technologies | $128.47
| 6/16/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/16/2026 |
TRIP TripAdvisor | $12.97
| 6/16/2026 | | Boost Price Target | $19.00 ➝ $20.00 | Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/16/2026 |
SYRE Spyre Therapeutics | $88.34
| 6/16/2026 | | Reiterated Rating | $100.00 | Outperform | 00.00% | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 6/16/2026 |
ROKU Roku | $138.07
| 6/16/2026 | | Downgrade | $155.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 6/16/2026 |
FLUT Flutter Entertainment | $101.78 -0.1% | 6/15/2026 | | Initiated Coverage | $138.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
DDOG Datadog | $223.00
| 6/15/2026 | | Initiated Coverage | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/15/2026 |
EPAM EPAM Systems | $76.37 -0.4% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
EPAM EPAM Systems | $76.37 -0.4% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
FLUT Flutter Entertainment | $101.78 -0.1% | 6/15/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
NTLA Intellia Therapeutics | $15.67
| 6/15/2026 | | Reiterated Rating | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/15/2026 |
CLYM Climb Bio | $11.45
| 6/12/2026 | | Reiterated Rating | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 6/12/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $21.23
| 6/12/2026 | | Reiterated Rating | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 6/12/2026 |
IDYA IDEAYA Biosciences | $31.23
| 6/12/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/12/2026 |
IMNM Immunome | $18.74
| 6/12/2026 | | Reiterated Rating | $31.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 6/12/2026 |
ORCL Oracle | $184.66 +0.2% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ORCL Oracle | $184.66 +0.2% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ARGX argenex | $877.72
| 6/11/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/11/2026 |
CGEM Cullinan Therapeutics | $15.03
| 6/11/2026 | | Reiterated Rating | $37.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 6/11/2026 |
RBRK Rubrik | $70.28 +0.1% | 6/11/2026 | | Reiterated Rating | $90.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/11/2026 |
DDOG Datadog | $223.00
| 6/10/2026 | | Boost Price Target | $220.00 ➝ $260.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/10/2026 |
IRON Disc Medicine | $70.79
| 6/10/2026 | | Reiterated Rating | $88.00 | Outperform | 00.00% | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 6/10/2026 |
NICE NiCE | $84.68
| 6/10/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Neutral | 00.00% | View details for Wedbush rating of NiCE (NASDAQ:NICE) on 6/10/2026 |
RNAC Cartesian Therapeutics | $9.63
| 6/10/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/10/2026 |
VFS VinFast Auto | $3.04
| 6/10/2026 | | Reiterated Rating | $6.00 | Outperform | 00.00% | View details for Wedbush rating of VinFast Auto (NASDAQ:VFS) on 6/10/2026 |
ZS Zscaler | $124.85
| 6/10/2026 | | Reiterated Rating | $220.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 6/10/2026 |
NUVL Nuvalent | $123.43
| 6/9/2026 | | Downgrade | $125.00 ➝ $124.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 6/9/2026 |
CROX Crocs | $125.05
| 6/8/2026 | | Initiated Coverage | | Buy ➝ Outperform | 00.00% | View details for Wedbush rating of Crocs (NASDAQ:CROX) on 6/8/2026 |
CBRS Cerebras Systems | $234.84 +0.1% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
CBRS Cerebras Systems | $234.84 +0.1% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
CTSH Cognizant Technology Solutions | $43.70
| 6/8/2026 | | Upgrade | $56.00 ➝ $70.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 6/8/2026 |
CBRS Cerebras Systems | $234.84 +0.1% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
AAPL Apple | $298.01
| 6/5/2026 | | Reiterated Rating | $400.00 | Outperform | 00.00% | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 6/5/2026 |
DOCU Docusign | $43.47
| 6/5/2026 | | Lower Price Target | $60.00 ➝ $58.00 | Neutral | 00.00% | View details for Wedbush rating of Docusign (NASDAQ:DOCU) on 6/5/2026 |
PL Planet Labs PBC | $28.18 -0.2% | 6/5/2026 | | Reiterated Rating | $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 6/5/2026 |
PLTR Palantir Technologies | $128.47
| 6/5/2026 | | Reiterated Rating | $230.00 | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/5/2026 |
RBRK Rubrik | $70.28 +0.1% | 6/5/2026 | | Reiterated Rating | $90.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/5/2026 |
AI C3.ai | $10.31 +0.0% | 6/4/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of C3.ai (NYSE:AI) on 6/4/2026 |
ARGX argenex | $877.72
| 6/4/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/4/2026 |
CRWD CrowdStrike | $684.86
| 6/4/2026 | | Boost Price Target | $700.00 ➝ $720.00 | Outperform | 00.00% | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 6/4/2026 |
Read now. Do not delete. You’ve been warned. (Ad) Three Nobel Prize Winners expose this once-in-a-generation wealth shift:
“Don’t Say I Didn’t Warn You”
Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. Don’t be left behind. Click here now. |
INOD Innodata | $95.38 -0.1% | 6/4/2026 | | Boost Price Target | $100.00 ➝ $120.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 6/4/2026 |
PANW Palo Alto Networks | $287.78
| 6/3/2026 | | Boost Price Target | $300.00 ➝ $340.00 | Outperform | 00.00% | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 6/3/2026 |
RZLT Rezolute | $5.02
| 6/3/2026 | | Boost Price Target | $5.00 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 6/3/2026 |
TVTX Travere Therapeutics | $55.15
| 6/3/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 6/3/2026 |
META Meta Platforms | $577.22
| 6/2/2026 | | Upgrade | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 6/2/2026 |
IBM International Business Machines | $249.72 +0.2% | 6/2/2026 | | Set Price Target | $350.00 | | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 6/2/2026 |
TRIP TripAdvisor | $12.97
| 6/2/2026 | | Initiated Coverage | $19.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026 |
ABVX Abivax | $99.15
| 6/2/2026 | | Upgrade | $110.00 ➝ $90.00 | Underperform ➝ Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 6/2/2026 |
IDYA IDEAYA Biosciences | $31.23
| 6/2/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/2/2026 |
JBIO Jade Biosciences | $16.82
| 6/2/2026 | | Boost Price Target | $34.00 ➝ $45.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 6/2/2026 |
ODTX Odyssey Therapeutics | $19.07
| 6/2/2026 | | Initiated Coverage | $30.00 | Outperform | 00.00% | View details for Wedbush rating of Odyssey Therapeutics (NASDAQ:ODTX) on 6/2/2026 |
PRAX Praxis Precision Medicines | $282.31
| 6/2/2026 | | Lower Price Target | $166.00 ➝ $162.00 | Underperform | 00.00% | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2026 |
TRIP TripAdvisor | $12.97
| 6/2/2026 | | Initiated Coverage | $19.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026 |
EWTX Edgewise Therapeutics | $36.87 +0.2% | 6/1/2026 | | Boost Price Target | $46.00 ➝ $52.00 | Outperform | 00.00% | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/1/2026 |
RVMD Revolution Medicines | $162.99
| 6/1/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 6/1/2026 |
REPL Replimune Group | $10.19
| 6/1/2026 | | Boost Price Target | $2.00 ➝ $6.00 | Neutral | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 6/1/2026 |
DY Dycom Industries | $456.23 -0.1% | 5/29/2026 | | Set Price Target | $654.00 | | 00.00% | View details for Wedbush rating of Dycom Industries (NYSE:DY) on 5/29/2026 |
VOYG Voyager Technologies | $37.61 +0.1% | 5/29/2026 | | Boost Price Target | $46.00 ➝ $60.00 | Outperform | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 5/29/2026 |
OKTA Okta | $117.81
| 5/29/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of Okta (NASDAQ:OKTA) on 5/29/2026 |
BBY Best Buy | $74.89 +0.2% | 5/29/2026 | | Boost Price Target | $70.00 ➝ $75.00 | Neutral | 00.00% | View details for Wedbush rating of Best Buy (NYSE:BBY) on 5/29/2026 |
COGT Cogent Biosciences | $34.54
| 5/29/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 5/29/2026 |
ESTC Elastic | $58.89 -0.1% | 5/29/2026 | | Lower Price Target | $74.00 ➝ $65.00 | Outperform | 00.00% | View details for Wedbush rating of Elastic (NYSE:ESTC) on 5/29/2026 |
IBM International Business Machines | $249.72 +0.2% | 5/29/2026 | | Reiterated Rating | $320.00 | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/29/2026 |
MDB MongoDB | $332.75
| 5/29/2026 | | Boost Price Target | $380.00 ➝ $390.00 | Outperform | 00.00% | View details for Wedbush rating of MongoDB (NASDAQ:MDB) on 5/29/2026 |
NTAP NetApp | $159.71
| 5/29/2026 | | Boost Price Target | $115.00 ➝ $150.00 | Neutral | 00.00% | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 5/29/2026 |
S SentinelOne | $15.01 -0.1% | 5/29/2026 | | Reiterated Rating | $20.00 | Outperform | 00.00% | View details for Wedbush rating of SentinelOne (NYSE:S) on 5/29/2026 |
STAA STAAR Surgical | $29.12
| 5/29/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/29/2026 |
P Everpure | $74.73 +0.2% | 5/28/2026 | | Boost Price Target | $100.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Everpure (NYSE:P) on 5/28/2026 |
SNOW Snowflake | $232.49 +0.1% | 5/28/2026 | | Boost Price Target | $270.00 ➝ $280.00 | Outperform | 00.00% | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 5/28/2026 |
CRM Salesforce | $151.67 -0.1% | 5/28/2026 | | Reiterated Rating | $325.00 | Outperform | 00.00% | View details for Wedbush rating of Salesforce (NYSE:CRM) on 5/28/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $21.23
| 5/28/2026 | | Initiated Coverage | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 5/28/2026 |
NUVL Nuvalent | $123.43
| 5/28/2026 | | Reiterated Rating | $125.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 5/28/2026 |
APGE Apogee Therapeutics | $90.38
| 5/27/2026 | | Boost Price Target | $120.00 ➝ $135.00 | Outperform | 00.00% | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 5/27/2026 |
CRBP Corbus Pharmaceuticals | $8.26
| 5/27/2026 | | Lower Price Target | $38.00 ➝ $30.00 | Outperform | 00.00% | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/27/2026 |
CRWD CrowdStrike | $684.86
| 5/27/2026 | | Boost Price Target | $550.00 ➝ $700.00 | Outperform | 00.00% | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 5/27/2026 |
PANW Palo Alto Networks | $287.78
| 5/27/2026 | | Boost Price Target | $225.00 ➝ $300.00 | Outperform | 00.00% | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 5/27/2026 |
RNAC Cartesian Therapeutics | $9.63
| 5/27/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/27/2026 |
ZS Zscaler | $124.85
| 5/27/2026 | | Lower Price Target | $300.00 ➝ $220.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 5/27/2026 |
OKLO Oklo | $61.15 0.0% | 5/26/2026 | | Reiterated Rating | $110.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/26/2026 |
TENB Tenable | $26.87
| 5/26/2026 | | Reiterated Rating | $29.00 | Outperform | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 5/26/2026 |
COAG Hemab Therapeutics | $29.24
| 5/26/2026 | | Initiated Coverage | $42.00 | Outperform | 00.00% | View details for Wedbush rating of Hemab Therapeutics (NASDAQ:COAG) on 5/26/2026 |
IBM International Business Machines | $249.72 +0.2% | 5/21/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/21/2026 |
NVDA NVIDIA | $210.69
| 5/21/2026 | | Boost Price Target | $300.00 ➝ $330.00 | Outperform | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/21/2026 |
GLOB Globant | $30.80 +0.2% | 5/18/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/18/2026 |
LRMR Larimar Therapeutics | $3.64 -0.1% | 5/18/2026 | | Lower Price Target | $13.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 5/18/2026 |
NVDA NVIDIA | $210.69
| 5/18/2026 | | Reiterated Rating | $300.00 | Buy | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/18/2026 |
GLOB Globant | $30.80 +0.2% | 5/15/2026 | | Set Price Target | $54.00 | | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/15/2026 |
DT Dynatrace | $41.41 0.0% | 5/15/2026 | | Set Price Target | $48.00 | | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/15/2026 |
SOLV Solventum | $75.72 +0.4% | 5/15/2026 | | Initiated Coverage | $94.00 | Outperform | 00.00% | View details for Wedbush rating of Solventum (NYSE:SOLV) on 5/15/2026 |
SBUX Starbucks | $100.65
| 5/14/2026 | | Initiated Coverage | | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 5/14/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
ANRO Alto Neuroscience | $22.68 -0.3% | 5/14/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Neutral | 00.00% | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/14/2026 |
KLRS Kalaris Therapeutics | $4.72
| 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
AVTX Avalo Therapeutics | $14.70
| 5/14/2026 | | Lower Price Target | $40.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026 |
INOD Innodata | $95.38 -0.1% | 5/14/2026 | | Boost Price Target | $80.00 ➝ $100.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/14/2026 |
KLRS Kalaris Therapeutics | $4.72
| 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
PL Planet Labs PBC | $28.18 -0.2% | 5/14/2026 | | Boost Price Target | $40.00 ➝ $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 5/14/2026 |
STAA STAAR Surgical | $29.12
| 5/14/2026 | | Upgrade | $26.00 ➝ $40.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/14/2026 |
TNGX Tango Therapeutics | $27.97
| 5/14/2026 | | Boost Price Target | $19.00 ➝ $33.00 | Outperform | 00.00% | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 5/14/2026 |
TSEM Tower Semiconductor | $286.74
| 5/14/2026 | | Boost Price Target | $140.00 ➝ $300.00 | Neutral | 00.00% | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 5/14/2026 |
VOR Vor Biopharma | $14.49
| 5/14/2026 | | Boost Price Target | $15.00 ➝ $18.00 | Neutral | 00.00% | View details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 5/14/2026 |